Biotechnology Research Reports

  The global platelet rich plasma market size is expected to reach   USD 1.94 billion by 2030 , registering a CAGR of 15.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.   Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade. Gather more insights about the market drivers, restrains and growth of the  Global Plat...

  The global mRNA synthesis raw materials market size is projected to reach   USD 1.99 billion by 2030 , according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.85% from 2024 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.   Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets ...

  The global synthetic biology market size is expected to reach   USD 42.06 billion by 2030 , registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.   Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the N...

  The Europe, CIS & Africa Spatial Transcriptomics Market   The spatial transcriptomics market in Europe, CIS, and Africa is experiencing significant growth. In 2023, it was valued at  USD 93.9 million , and it's projected to expand at a Compound Annual Growth Rate (CAGR) of 15.57% from 2024 to 2030.  Key Drivers of Market Growth:   Several factors are contributing to this robust growth:  Advancements in Spatial Omics: The emergence of spatial omics analysis, particularly in cancer research, is revolutionizing our understanding of biological processes. The development of fourth-generation sequencing (in-situ sequencing) is further propelling the field by enabling direct sequencing of RNA and DNA within tissues. Increased Research Funding and Collaboration: Significant investments and collaborative efforts in spatial biology research are fueling innovation and accelerating the development of new technologies and applications. Rising Cancer Prevalence: Th...

  The global biomaterials market size was estimated at   USD 178.0 billion in 2023   and is projected to grow at a CAGR of 15.6% from 2024 to 2030. The growing incidence of musculoskeletal and chronic skeletal medical conditions is expected to stimulate the demand for implants based on biomaterials, thereby enhancing market expansion. The increasing prevalence of chronic conditions such as osteoarthritis and degenerative diseases intensifies the demand for advanced biomaterials. Joint replacements and augmentations become essential interventions for individuals facing limited mobility and pain due to these conditions.   Metallic biomaterials address this need by offering durable and long-lasting solutions that integrate with the body, restoring functionality and enhancing the quality of life for affected individuals. Technological advancements continually refine biomaterials, tailoring them to meet specific medical requirements. Innovations focus on improving biocomp...

  The global  biomaterials market  size is expected to reach USD 488.70 billion by 2030, registering a CAGR of 15.6% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.    Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medi...